Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and efficacy evaluation of Dotarem in MRI for CNS lesions
2010-020319-34Phase 4Completed
- Sponsor
- Guerbet
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of gadoterate meglumine in acute neurological injury, sponsored by Guerbet. Primary endpoint: Lesion visualization (primary). Started Jul 2010; status: completed.
02
Drugs
gadoterate meglumine
03
Conditions
acute neurological injury
Beyond the preview
Go deeper on 2010-020319-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020319-34.